ACTIVE

APOTHEEK PUTTEMANS-VERNAILLEN

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result148 k €+4,1 %over 1 year
Gross margin413,3 k €+8,4 %over 1 year
Equity897,5 k €+5,6 %over 1 year
Workforce2,0 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK PUTTEMANS-VERNAILLEN is a Public limited company incorporated in 1985. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Putte. It employs on average 2,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0427.909.758
Incorporation
30/09/1985
Legal form
Public limited company
Registered office
Lierbaan 37
2580 Putte · FlandreSee on map
Contributed capital
62 000,00 €
Latest accounts
31/12/2025
Average workforce
2,0 ETP
Joint committees (2)
  • 313
  • 330
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 19 filings

Trend over 17 financial years

20252024202320222021
Income statement
Gross margin413,3 k €381,3 k €337,4 k €335,1 k €260 k €
EBITDA270,8 k €249,7 k €208,6 k €212,1 k €156,9 k €
Operating result205,3 k €195,5 k €151,5 k €153,6 k €95,5 k €
Net result148 k €142,1 k €108,1 k €108,7 k €64,8 k €
Balance sheet
Equity897,5 k €849,5 k €707,4 k €699,3 k €696,6 k €
Total assets1,2 M €1,1 M €1,1 M €1,1 M €1,1 M €
Cash143 k €194,1 k €131,2 k €140,1 k €146,2 k €
Debts296,4 k €299,8 k €353,9 k €376,7 k €416,2 k €
Other
Workforce2,0 ETP2,0 ETP2,0 ETP2,0 ETP2,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 22 ended

Active mandates

Panacea Pharma

Managing director · since 12 octobre 2023 · 0501.960.053

Represented by Puttemans Stefan

Active

Ended mandates

Panacea Pharma

Director · since 01 avril 2021 · until 31 décembre 2024 · 0501.960.053

Represented by Freya Vandenplas

Ended
Myriam Vernaillen

Director · since 31 décembre 2018 · until 31 décembre 2024

Ended
Panacea Pharma

Managing director · since 31 décembre 2018 · until 31 décembre 2024 · 0501.960.053

Represented by Vandenplas FREYA

Ended
Panacea Pharma

Managing director · since 31 décembre 2018 · until 12 octobre 2029 · 0501.960.053

Represented by Puttemans STEFAN

Ended

Other companies at this address

Lierbaan 37 2580 Putte
CompanyCBE no.
Panacea Pharma● Active
0501.960.053
Vereniging van mede-eigenaars Residentie De Farmacie● Active
0749.640.150

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date16/06/202627/06/202510/06/202407/06/202320/06/202210/08/2021
General meeting01/06/202602/06/202503/06/202405/06/202307/06/202207/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202501/06/202616/06/2026DutchPDF
Abridged model31/12/202402/06/202527/06/2025DutchPDF
Abridged model31/12/202303/06/202410/06/2024DutchPDF
Abridged model31/12/202205/06/202307/06/2023DutchPDF
Abridged model31/12/202107/06/202220/06/2022DutchPDF
Abridged model31/12/202007/06/202110/08/2021DutchPDF
Abridged model31/12/201902/06/202005/08/2020DutchPDF
Abridged model31/12/201803/06/201919/06/2019DutchPDF
Abridged model31/12/201704/06/201824/08/2018DutchPDF
Abridged model31/12/201605/06/201701/08/2017DutchPDF
Abridged model31/12/201506/06/201613/06/2016DutchPDF
Abridged model31/12/201401/06/201506/08/2015DutchPDF
Abridged model31/12/201302/06/201401/08/2014DutchPDF
Abridged model31/12/201203/06/201330/08/2013DutchPDF
Abridged model31/12/201104/06/201228/09/2012DutchPDF
Abridged model31/12/201018/06/201125/11/2011DutchPDF
Abridged model31/12/200907/06/201031/08/2010DutchPDF
Abridged model31/12/200802/06/200928/10/2009DutchPDF
Abridged model31/12/200622/06/200719/10/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 22 ended

Active mandates

Panacea Pharma

Managing director · since 12 octobre 2023 · 0501.960.053

Represented by Puttemans Stefan

Active

Ended mandates

Panacea Pharma

Director · since 01 avril 2021 · until 31 décembre 2024 · 0501.960.053

Represented by Freya Vandenplas

Ended
Myriam Vernaillen

Director · since 31 décembre 2018 · until 31 décembre 2024

Ended
Panacea Pharma

Managing director · since 31 décembre 2018 · until 31 décembre 2024 · 0501.960.053

Represented by Vandenplas FREYA

Ended
Panacea Pharma

Managing director · since 31 décembre 2018 · until 12 octobre 2029 · 0501.960.053

Represented by Puttemans STEFAN

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates28/11/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - BENAMING - DIVERSEN - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates17/01/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates25/02/2013
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates15/12/2010
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025148 k €↑
  2. 2024
    Annual accounts 2024142,1 k €↑
  3. 2023
    Annual accounts 2023108,1 k €↓
  4. 2022
    Annual accounts 2022108,7 k €↑
  5. 2021
    Annual accounts 202164,8 k €↑
  6. 2018
    Annual accounts 201823,6 k €↓
  7. 2017
    Annual accounts 201772,9 k €↑
  8. 2016
    Annual accounts 201669,1 k €↑
  9. 2015
    Annual accounts 201567,6 k €↑
  10. 2014
    Annual accounts 201463,1 k €↓
  11. 2013
    Annual accounts 201372,9 k €↑
  12. 2012
    Annual accounts 201263,9 k €↑
  13. 2011
    Annual accounts 201144,9 k €↓
  14. 2010
    Annual accounts 201046,8 k €↓
  15. 2009
    Annual accounts 200962 k €↓
  16. 2008
    Annual accounts 200872,6 k €↑
  17. 2006
    Annual accounts 200635,4 k €
  18. 30/09/1985
    IncorporationPublic limited company